Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
27
天
The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions
作者
Á.Guerrero Zotano; T.M. Allweis; R. Foerster; C. Palmieri; O. Gluz; S. Chia; C. Sotiriou; G. Bianchini展开收起
作者单位
Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain; GEICAM, Spanish Breast Cancer Group, Madrid, Spain; Dept. of Breast Surgery, Hadassah Medical Center, Jerusalem, Israel; Faculty of Medicine, Hebrew University, Jerusalem, Israel; Exact Sciences (Abbott Cancer Diagnostics), Baar, Zug, Switzerland; The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK; University of Liverpool, Liverpool, UK; West German Study Group (WSG), Moenchengladbach, Germany; Breast Center Niederrhein, Ev. Hospital Bethesda, Moenchengladbach, Germany; University Clinics Cologne, Women’s Clinic and Breast Center, Cologne, Germany; Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada; Breast Cancer Translational Research Laboratory, Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Brussels, Belgium; Université Libre de Bruxelles (ULB), Brussels, Belgium; Medical Oncology Department, IRCCS San Raffaele Hospital, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy展开收起
62
天
Prognostic role of postoperative circulating tumor DNA in metastatic colorectal cancer treated with curative intent: A systematic review and meta-analysis
作者
Claudia Cardone; Sergio Facchini; Bruna de Oliveira Ascef; Antonino Cassata; Alfonso De Stefano; Paolo Chiodini; Antonio Avallone展开收起
作者单位
Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori- IRCCS-Fondazione G. Pascale, Naples, Italy; Department of Mental and Physical Health and Preventive Medicine. Medical Statistics Unit. Università degli Studi della Campania Luigi Vanvitelli, Naples, Italy展开收起
64
天
Central nervous system and leptomeningeal metastases in patients with HER2-positive breast cancer: A comprehensive review and therapeutic algorithm proposal
作者
Aldo Caltavituro; Roberto Buonaiuto; Alessandra Longobardi; Paola Trasacco; Claudia Martinelli; Giuseppe Di Grazia; Roberto Pacelli; Grazia Arpino; Carmine De Angelis; Roberta Caputo; Michelino De Laurentiis; Elena Laakmann; Leonor Vasconcelos de Matos; Mário Fontes-Sousa; Mette van Ramshorst; Volkmar Mueller; Elisa Agostinetto; Sabine Linn; Michelangelo De Angelis; Francesco Schettini; Mario Giuliano展开收起
作者单位
Oncology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy; Clinical and Translational Oncology, Scuola Superiore Meridionale, Naples, Italy; Translational Genomics and Targeted Therapies in Solid Tumors, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain; Department of Breast and Thoracic Oncology, Istituto Nazionale Tumori IRCCS “Fondazione G. Pascale”, Napoli, Italy; Department of Advanced Biomedical Sciences, University Federico II, Naples, Italy; University Medical Center Hamburg-Eppendorf, Department of Gynecology, Hamburg, Germany; Breast Cancer Unit, Champalimaud Clinical Centre, Champalimaud Foundation, Lisbon, Portugal; Oncology Unit, Hospital CUF Tejo, Lisbon, Portugal, Oncology Unit, Unidade Local de Saúde Lisboa Ocidental, Lisbon, Portugal; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Gynecology, University Medical Center Hamburg 20246 Hamburg, Germany; Université libre de Bruxelles (ULB), Hôpital Universitaire de Bruxelles (H.U.B), Institut Jules Bordet, Bruxelles, Belgium; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands; IRCCS Istituto Neurologico Mediterraneo Neuromed, Division of Neurosurgery, Isernia, Italy; Clinic Barcelona Comprehensive Cancer Center, Hospital Clinic of Barcelona, Barcelona, Spain; Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain展开收起
37
天
KRAS G12C-mutant non-small cell lung cancer: A practical guide for clinicians
作者
Jordi Remon; Giulia La-Cava; Maxime Borgeaud; Stephanie P.L. Saw; Lizza EL Hendriks; Biagio Ricciuti展开收起
作者单位
Department of Medical Oncology, Thoracic Group, Gustave Roussy, Villejuif, France; Paris-Saclay University, Paris, France; Department of Medicine and Surgery, University Campus Bio-Medico of Rome, Rome, Italy; Oncology Department, University Hospital Geneva, Geneva, Switzerland; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Department of Pulmonary Diseases, Maastricht University Medical Centre (+), GROW Research Institute for Oncology and Reproduction, Maastricht, the Netherlands; Lowe Center of Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States展开收起
32
天
Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis
作者
Pedro C. Abrahão Reis; Mariana Macambira Noronha; João Pedro Oliveira; João Evangelista Ponte Conrado; Isabella Romagnoli Buonopane; Carlos Diego Holanda Lopes; Daniel V. Araujo; Erick F. Saldanha展开收起
作者单位
Universidade Federal do Rio de Janeiro (UFRJ), RJ, Brazil; Universidade Federal do Ceará (UFC), CE, Brazil; Universidade Federal da Bahia (UFBA), BA, Brazil; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, ON, Canada; Department of Medicine, University of Toronto, ON, Canada; University of Florida, Gainesville, FL, USA; Harvard T. H. Chan School of Public Health, Harvard University, MA, USA展开收起
57
天
Targeting key epigenetic regulators in solid tumors: focus on EZH2, PRMT5, and BET inhibitors
作者
Irene Hernández de Córdoba Sánchez; Mercedes Avedillo Ruidiaz; Victor Moreno; Henry Long; Paloma Cejas展开收起
作者单位
Department of Medical Oncology, University Hospital Infanta Sofía, San Sebastián de los Reyes, 28702 Madrid, Spain; Department of Medical Oncology, University Hospital Fundación Jiménez Díaz, Moncloa-Aravaca, 28040 Madrid, Spain; START Madrid-FJD Early Phase Clinical Trials Unit, University Hospital Fundación Jiménez Díaz, 28040 Madrid, Spain; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA展开收起
FAQ
CANCER TREATMENT REVIEWS审稿要多久?
截至2026-11-19,CrushSCI 收录了 CANCER TREATMENT REVIEWS 的 10 篇完整审稿记录。最快一篇从收稿到录用用了 27 天(The role of the 21-gene assay in the neoadjuvant setting for hormone receptor-positive HER2-negative breast cancer: Impact on systemic and surgical treatment decisions,2026-04-28 收稿,2026-05-25 录用),最慢一篇用了 66 天;平均 47.6 天,中位数 48.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
